Specialty Pharma Journal Specialty, Precision & Technology

BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji …

WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that the second randomized, vehicle-controlled, pivotal Phase 3 study …

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …

NEW YORK–(BUSINESS WIRE)–Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Euronext Growth: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on …

CAMPBELL, Calif.–(BUSINESS WIRE)–Saama Technologies, Inc., the number one AI clinical analytics platform company, announced today that …

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused …

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that the U.S. Food and Drug Administration …

Baxter International Inc. (NYSE:BAX), a leading global medical products company, has completed its previously announced acquisition of Seprafilm Adhesion …

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that full results from its Phase 2 clinical …

TEL AVIV, Israel and BETHESDA, Maryland, Feb. 18, 2020 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: …

RESEARCH TRIANGLE PARK, N.C., Feb. 18, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced that …

DUBLIN, Ireland & BURLINGAME, Calif.–(BUSINESS WIRE)–ALX Oncology, a clinical-stage immuno-oncology company developing therapies to block …

MADRID and DUBLIN, Feb. 17, 2020 /PRNewswire/ — PharmaMar (MSE:PHM) and Jazz Pharmaceuticals plc (Nasdaq: …

SALT LAKE CITY, Feb. 14, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a …